BWM
VRTX icon

Bernard Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bernard Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.23K Hold
5
– – ﹤0.01% 285
2025
Q4 		$2.27K Hold
5
– – ﹤0.01% 274
2025
Q3 		$1.96K Hold
5
– – ﹤0.01% 273
2025
Q2 		$2.23K Sell
5
-3
-38% -$1.38K ﹤0.01% 262
2025
Q1 		$3.88K Buy
+8
New +$3.73K ﹤0.01% 270

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bernard Wealth Management's VRTX Position: Q1 2026 in Review

Bernard Wealth Management held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 5 shares worth $2.23K. The position accounts for ﹤0.01% of the portfolio, ranked #285.

Bernard Wealth Management first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.88K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Bernard Wealth Management held 5 shares of Vertex Pharmaceuticals worth $2.23K as of Q1 2026.
  • Bernard Wealth Management left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Bernard Wealth Management's portfolio in Q1 2026, its #285 holding.
  • Bernard Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Bernard Wealth Management's Vertex Pharmaceuticals position peaked at $3.88K in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Bernard Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.